Background and Purpose—Both stroke and the apolipoprotein E (APOE) e4 allele increase the risk of dementia. However, the interaction between stroke and APOE on dementia is still unclear. We addressed this topic by using a longitudinal design. Methods—We followed up a community cohort of 1301 subjects aged $75 years, who did not have dementia at baseline. Among them, 92 subjects had a history of stroke (from 3 months to 16 years before baseline interview). After the 3-year follow-up, 224 dementia cases had been diagnosed. During the period of follow-up, 91 subjects had a first occurrence of stroke (incident stroke). The APOE genotype was known for 985 subjects. Cox proportional hazards regression models were constructed to estimate the risk ...
We investigated the status of the apolipoprotein E allele in 538 participants in the incidence phase...
Background: Identifying independent and interactive associations of a wide range of diseases and mul...
Background: dementia risk conferred by apolipoprotein-E (APOE) and angiotensin-1-converting enzyme (...
textabstractOBJECTIVE: To investigate the association between the apolipoprotein E (APOE) genotypes ...
BACKGROUND AND PURPOSE: Stroke and apolipoprotein E epsilon4 (ApoE epsilon4) are individually import...
Introduction. Evidence from clinical samples and geographically limited population studies suggests ...
Introduction. Evidence from clinical samples and geographically limited population studies suggests ...
OBJECTIVES: To provide risk estimates of dementia and Alzheimer disease as a function of the apolipo...
It is unclear how the APOE genotype contributes to the incidence of vascular diseases and dementia. ...
It is unclear how the APOE genotype contributes to the incidence of vascular diseases and dementia. ...
It is unclear how the APOE genotype contributes to the incidence of vascular diseases and dementia. ...
Aims: apolipoprotein E (APOE) genotype is the major genetic risk factor for sporadic Alzheimer's dis...
Aims: Apolipoprotein E (APOE) genotype is the major genetic risk factor for sporadic Alzheimer's dis...
Aims: Apolipoprotein E (APOE) genotype is the major genetic risk factor for sporadic Alzheimer's dis...
Background and Purpose — APOE-ε4 genotype is a risk factor for sporadic Alzheimer disease and reduce...
We investigated the status of the apolipoprotein E allele in 538 participants in the incidence phase...
Background: Identifying independent and interactive associations of a wide range of diseases and mul...
Background: dementia risk conferred by apolipoprotein-E (APOE) and angiotensin-1-converting enzyme (...
textabstractOBJECTIVE: To investigate the association between the apolipoprotein E (APOE) genotypes ...
BACKGROUND AND PURPOSE: Stroke and apolipoprotein E epsilon4 (ApoE epsilon4) are individually import...
Introduction. Evidence from clinical samples and geographically limited population studies suggests ...
Introduction. Evidence from clinical samples and geographically limited population studies suggests ...
OBJECTIVES: To provide risk estimates of dementia and Alzheimer disease as a function of the apolipo...
It is unclear how the APOE genotype contributes to the incidence of vascular diseases and dementia. ...
It is unclear how the APOE genotype contributes to the incidence of vascular diseases and dementia. ...
It is unclear how the APOE genotype contributes to the incidence of vascular diseases and dementia. ...
Aims: apolipoprotein E (APOE) genotype is the major genetic risk factor for sporadic Alzheimer's dis...
Aims: Apolipoprotein E (APOE) genotype is the major genetic risk factor for sporadic Alzheimer's dis...
Aims: Apolipoprotein E (APOE) genotype is the major genetic risk factor for sporadic Alzheimer's dis...
Background and Purpose — APOE-ε4 genotype is a risk factor for sporadic Alzheimer disease and reduce...
We investigated the status of the apolipoprotein E allele in 538 participants in the incidence phase...
Background: Identifying independent and interactive associations of a wide range of diseases and mul...
Background: dementia risk conferred by apolipoprotein-E (APOE) and angiotensin-1-converting enzyme (...